Quarterly report pursuant to Section 13 or 15(d)

Temporary Equity and Stockholders' Deficiency - Schedule of Warrants Outstanding and Exercisable (Details)

v3.20.2
Temporary Equity and Stockholders' Deficiency - Schedule of Warrants Outstanding and Exercisable (Details)
 9 Months Ended
Sep. 30, 2020
$ / shares
shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Warrants Outstanding, Number of Warrants 8,061,227
Warrants Exercisable, Number of Warrants 8,061,227
Range of Exercise Price 0.34 [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Warrants Outstanding, Exercise Price | $ / shares $ 0.34
Warrants Outstanding Exercisable, Description Common Stock
Warrants Outstanding, Number of Warrants 7,653,276
Warrants Exercisable, Weighted Average Remaining Life in Years 1 year
Warrants Exercisable, Number of Warrants 7,653,276
Range of Exercise Price 2.00 [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Warrants Outstanding, Exercise Price | $ / shares $ 2.00
Warrants Outstanding Exercisable, Description Common Stock
Warrants Outstanding, Number of Warrants 281,660
Warrants Exercisable, Weighted Average Remaining Life in Years 10 months 25 days
Warrants Exercisable, Number of Warrants 281,660
Range of Exercise Price 2.50 [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Warrants Outstanding, Exercise Price | $ / shares $ 2.50
Warrants Outstanding Exercisable, Description Common Stock
Warrants Outstanding, Number of Warrants 126,291
Warrants Exercisable, Weighted Average Remaining Life in Years 6 months
Warrants Exercisable, Number of Warrants 126,291